HOME Research Insight Roche Diagnostics Limited (Switzerland) and Siemens Healthcare (Germany) Dominate the Global In Vitro Diagnostics (IVD) Market



Roche Diagnostics Limited (Switzerland) and Siemens Healthcare (Germany) Dominate the Global In Vitro Diagnostics (IVD) Market


The global IVD market is consolidated and highly competitive, with the top five players accounting for ~57% of the market share in 2014. A majority of the leading players in this market are based in developed countries across North America and Europe.

In this consolidated market, Roche Diagnostics Limited (Switzerland) and Siemens Healthcare (Germany) are the leading companies, followed by Danaher Corporation (U.S.) and Abbott Laboratories, Inc. (U.S.). The leading position of Roche Diagnostics Limited (Switzerland) is mainly attributed to its diversified product portfolio, which includes a wide range of IVD tests. The company continuously focuses on developing innovative products, strengthening its existing product line, and increasing its market share by obtaining regulatory approvals. For instance, in May 2015, the company received FDA approval for its cobas KRAS Mutation, a polymerase chain reaction (PCR)-based diagnostics test. The company operates across the U.S., Europe, the Middle East, Africa, and Asia.

Siemens Healthcare (Germany) is another leading company in the global IVD market. The company has maintained its leadership position through its strong presence across the globe, covering major markets such as the Americas, Asia, Australia, Europe, the Middle East, and Africa. The company pursues strategies such as partnerships and agreements, new product launches, and expansions in emerging countries and untapped regions across the globe to maintain its position in the market and expand its foothold across the globe. For instance, in March 2015, the company launched three new scalable hematology systems such as ADVIA 360, ADVIA 560, and ADVIA 560 AL System.

In the past three years, a majority of the top players adopted geographic expansions, new product launches, and mergers and acquisitions as their key growth strategies. These players are mainly focusing on enhancing their presence in the high-growth markets such as China, India, Brazil, Russia, Korea, and Mexico. For instance, in 2014, Roche Diagnostics invested USD 492 million to increase its production capacity in China over a three-year period in order to fulfill the rising demand for its diagnostics tests. Similarly, in November 2012, Thermo Fisher Scientific established a new life sciences consumables and equipment manufacturing facility in China.

Related Reports:

In Vitro Diagnostics (IVD) Quality Control Market by Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology), Source (Serum, Whole Blood, Urine), Type (Instrument Specific, Third Party Control) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports